Modified oligonucleotides, capable of forming triple-stranded complexes with the CCR-5 chemokine receptor gene, are provided. The oligonucleotides bear cross-linking groups, capable of causing targeted modification of the CCR-5 gene. Such modifications can impair the ability of the CCR-5 gene product to serve as a co-receptor for human immunodeficiency viruses.
申请公布号
WO9834945(A1)
申请公布日期
1998.08.13
申请号
WO1998US02314
申请日期
1998.02.06
申请人
EPOCH PHARMACEUTICALS, INC.;MEYER, RICH, B., JR.;KUTYAVIN, IGOR V.